West Virginia College of Law professor S. Sean Tu recently published a new opinion piece in J AMA. The article, titled "Characteristics of Academic Inventors on Government-Linked US Drug Patents" is co-authored by Professor Tu with Matthew J. Martin, MA, Sarah M.E. Gabriele, LLM, MBE, and Aaron S. Kesselheim, MD, JD, MPH, all affiliated with the Program on Regulation, Therapeutics, and Law at Brigham and Women’s Hospital. It was published online by the journal on November 21, 2024.
From the abstract:
Although the National Institutes of Health (NIH) and other federal agencies are substantial investors in early-stage biomedical research, few drugs have patents linked to government funding. To understand the reasons for the low number of government-linked drug patents, we conducted a cross-sectional analysis of US drug patents linked to federal funding to understand how the characteristics of academic inventors may influence patenting decisions.
Find more of Professor Tu's scholarship on SSRN.